Latest total current liabilities for ACBM: $450K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest total current liabilities for ACBM is $450K as of June 2026. That compares with $370K in the prior-year period — up 20.9% year over year. Investors often review this figure alongside Acro Biomedical , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, ACBM's total current liabilities moved from $370K to $450K — a 20.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Acro Biomedical , Ltd.'s operating scale or balance-sheet position.
A total current liabilities figure of $450K for ACBM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting ACBM's total current liabilities ($450K), review year-over-year change from $370K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.